LOS ANGELES, May 4 (Xinhua) -- Anti-COVID-19 pill Paxlovid could reduce risks for COVID-19 related hospitalization, and early treatment with Paxlovid and other available authorized therapeutics could make a difference for high-risk patients, according to health experts.
Paxlovid is now widely available at community pharmacies in the United States, said the U.S. Food and Drug Administration (FDA) on Wednesday.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!